INVO Fertility, Inc.: diluted weighted-average shares

What this measure means

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Withheld reporting periods

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding: These 2014 INVO weighted-average shares are withheld because the main statement reports 112,672,160 while the per-share note reports 112,670,160 for the same annual period. The source disagreement is retained; neither number is substituted or treated as a rounding correction.

Reading these values

This selected numerical history matches Basic weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Context from the filing

INVO Fertility's 2024 and 2025 total loss EPS uses losses attributable to common shareholders, including preferred dividends and deemed dividends, rather than the separate continuing-operations EPS. The filing displays full dollar amounts and shares and retrospectively reflects one-for-12, one-for-3 and one-for-8 splits effective March 18, July 21 and November 28, 2025, and a one-for-5 split effective March 27, 2026. Potential shares are excluded as anti-dilutive during losses. Earlier INVO Bioscience observations retain their historical filing basis; both disputed 2014 share counts remain withheld. Read the source filing.

For INVO Bioscience in 2011–2014, potential shares were excluded from diluted loss per share because their inclusion would have been anti-dilutive during losses. The reviewed figures are USD EPS for those four years and full weighted-average share counts for 2011–2013. Both 2014 share counts remain withheld: the main statement reports 112,672,160 while the per-share note reports 112,670,160. EPS is retained as reported, not recomputed from either disputed denominator. These are the historical filing’s share and period conventions. Read the source filing.

Selected filing history

Related financial histories

• INVO Fertility, Inc.: total assets
• INVO Fertility, Inc.: total liabilities
• INVO Fertility, Inc.: stockholders equity
• INVO Fertility, Inc.: cash and cash equivalents
• INVO Fertility, Inc.: net income or loss
• INVO Fertility, Inc.: operating cash flow
• INVO Fertility, Inc.: capital expenditure payments
• INVO Fertility, Inc.: revenue
• INVO Fertility, Inc.: contract revenue excluding tax
• INVO Fertility, Inc.: financing cash flow
• INVO Fertility, Inc.: investing cash flow
• INVO Fertility, Inc.: retained earnings or deficit
• INVO Fertility, Inc.: basic weighted-average shares
• INVO Fertility, Inc.: basic earnings per share
• INVO Fertility, Inc.: diluted earnings per share
• INVO Fertility, Inc.: income tax expense or benefit
• INVO Fertility, Inc.: net property, plant and equipment
• INVO Fertility, Inc.: share-based compensation expense
• INVO Fertility, Inc.: operating income or loss
• INVO Fertility, Inc.: current assets
• INVO Fertility, Inc.: interest expense
• INVO Fertility, Inc.: current liabilities
• INVO Fertility, Inc.: current accounts payable
• INVO Fertility, Inc.: net finite-lived intangible assets
• INVO Fertility, Inc.: net current accounts receivable
• INVO Fertility, Inc.: operating expenses
• INVO Fertility, Inc.: net inventory
• INVO Fertility, Inc.: gross profit
• INVO Fertility, Inc.: cost of revenue
• INVO Fertility, Inc.: selling, general and administrative expense
• INVO Fertility, Inc.: research and development expense

Inspect the source

Entity

INVO Fertility, Inc. / CIK 0001417926

Captured

2026-09-20T08:02:38.408Z

SEC response SHA-256

685ad9dc506bdfe829560566a030c772be69de24616cba6e2a255a48eadc071b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001417926.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))